ANI Pharmaceuticals Inc (ANIP)
65.45
+0.86
(+1.33%)
USD |
NASDAQ |
Apr 19, 16:00
65.45
0.00 (0.00%)
After-Hours: 20:00
ANI Pharmaceuticals Profit Margin (Quarterly): 0.88% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.88% |
| September 30, 2023 | 7.54% |
| June 30, 2023 | 5.36% |
| March 31, 2023 | 1.35% |
| December 31, 2022 | -4.50% |
| September 30, 2022 | -10.26% |
| June 30, 2022 | -20.21% |
| March 31, 2022 | -31.22% |
| December 31, 2021 | -39.61% |
| September 30, 2021 | -8.54% |
| June 30, 2021 | -29.01% |
| March 31, 2021 | 0.16% |
| December 31, 2020 | -6.35% |
| September 30, 2020 | 0.82% |
| June 30, 2020 | -25.45% |
| March 31, 2020 | -14.09% |
| December 31, 2019 | -10.08% |
| September 30, 2019 | 7.59% |
| June 30, 2019 | 12.11% |
| March 31, 2019 | 0.85% |
| December 31, 2018 | 9.51% |
| September 30, 2018 | 9.93% |
| June 30, 2018 | 5.88% |
| March 31, 2018 | 4.84% |
| December 31, 2017 | -20.36% |
| Date | Value |
|---|---|
| September 30, 2017 | 9.80% |
| June 30, 2017 | 5.99% |
| March 31, 2017 | 3.15% |
| December 31, 2016 | -2.83% |
| September 30, 2016 | 6.60% |
| June 30, 2016 | 3.59% |
| March 31, 2016 | 6.55% |
| December 31, 2015 | 15.95% |
| September 30, 2015 | 22.83% |
| June 30, 2015 | 18.30% |
| March 31, 2015 | 23.24% |
| December 31, 2014 | 99.85% |
| September 30, 2014 | 38.80% |
| June 30, 2014 | -35.55% |
| March 31, 2014 | 30.82% |
| December 31, 2013 | 32.59% |
| September 30, 2013 | 15.20% |
| June 30, 2013 | -74.50% |
| March 31, 2013 | -1.58K% |
| December 31, 2012 | -202.7% |
| September 30, 2012 | -5.55K% |
| June 30, 2012 | -6.75K% |
| March 31, 2012 | -9.00K% |
| December 31, 2011 | -5.81K% |
| September 30, 2011 | -6.97K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-39.61%
Minimum
Dec 2021
12.11%
Maximum
Jun 2019
-8.61%
Average
-6.35%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 64.72% |
| ADMA Biologics Inc | -23.88% |
| Dentsply Sirona Inc | 6.62% |
| Allogene Therapeutics Inc | -- |
| Vanda Pharmaceuticals Inc | -5.30% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.64% |
| Return on Assets | 2.25% |
| Return on Invested Capital | 2.72% |
| Gross Profit Margin (Quarterly) | 59.42% |
| Operating Margin (Quarterly) | 6.62% |
| Return on Net Operating Assets | 3.23% |